Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/…
#CoreStocks #StockstoBuy #StockPicks These undervalued stocks with wide economic moats and consistent cash flows look attractive.
Nuclear power could be the answer for AI’s energy demands. Oklo and NuScale Power are well worth considering now.
Tech stocks outperformed the broader market last week. Sandisk, the NAND flash drive provider, was the top stock of the week, up 22%.
